Published works by Sofia Wilson

Published works

• UK clinical trials – new notification scheme for lowest-risk clinical trials

  BioSlice Blog · October 19, 2023

  LEX-WK-0NGTRY53
• New UK International Recognition Framework for Medicines

  BioSlice Blog · October 3, 2023

  LEX-WK-WXPFBDD7
• Legislative change is afoot for clinical trials conducted in the UK

  BioSlice Blog · July 21, 2023

  LEX-WK-J4X4H8SG
• New UK International Recognition Routes for Medicines   

  BioSlice Blog · July 14, 2023

  LEX-WK-JWN3NSW0
• UK Medical Devices Update: Implementation of the UK Medical Devices Regulations and new Innovative Devices Access Pathway

  BioSlice Blog · June 8, 2023

  LEX-WK-65GWSAYF
• Proposed Amendments to the EU Regulatory Framework for Medicinal Products

  BioSlice Blog · April 26, 2023

  LEX-WK-1SXJDPQJ
• Evaluation of New Active Substance Status for Biological Products in the EU

  BioSlice Blog · December 21, 2022

  LEX-WK-ADHM3SBK
• Adoption of New Procurement Regulations in the UK

  BioSlice Blog · December 1, 2022

  LEX-WK-4B4961RT
• Concern over high Scheme Payments under the UK VPAS

  BioSlice Blog · September 28, 2022

  LEX-WK-QZHG6NZ9
• EU Commission adopts Proposal for a Regulation on substances of human origin

  BioSlice Blog · July 27, 2022

  LEX-WK-FXGBCHA2
• EFPIA’s Response to EU Pharmaceutical Strategy Consultations

  BioSlice Blog · July 4, 2022

  LEX-WK-2YRFQPJ2
• Use of Real-World Evidence in the UK

  BioSlice Blog · May 25, 2022

  LEX-WK-TAQQ44T6
• EU Digital Health Policy: European Commission launches European Health Data Space

  BioSlice Blog · May 19, 2022

  LEX-WK-C9EHQZGS
• Important Milestone for CBD Products in England and Wales

  BioSlice Blog · April 1, 2022

  LEX-WK-JTW06SAS
• Brexit update: Supply of Medicines from Great Britain to Northern Ireland

  BioSlice Blog · February 17, 2022

  LEX-WK-BF5G12NF
• New EU Regulation Reinforcing the Role of the EMA

  BioSlice Blog · February 8, 2022

  LEX-WK-7EV1DWCE